INTRODUCTION
============

Interleukin 1 receptor-like 1 (IL1RL1), also called T1, ST2, DER4 and FIT-1, is a member of the interleukin 1 super-family \[[@R1]\] but does not bind interleukin 1 (IL1) \[[@R2]\]. IL1RL1 was an orphan receptor until the description of its ligand, interleukin-33 (IL33) in 2005 \[[@R3]\]. Since then, IL33 binding to IL1RL1 has been associated with a variety of disease states and in particular to inflammatory processes as outlined in recent reviews \[[@R4],[@R5]\]. In the present review, we will focus mainly on the genetic associations of *IL1RL1* with disease.

IL1RL1 GENE AND PROTEINS
========================

The *IL1RL1* gene is located in chromosome 2q12 and is composed of 11 exons \[[@R6]\]. A number of IL1 family members reside in the immediate vicinity of the *IL1RL1*gene namely *IL1R2,* *IL1R1, IL1RL2*, IL18 receptor 1 (*IL18R1)* and IL18 receptor accessory protein*(IL18RAP)*. The region spans about 300 kb and is in high linkage disequilibrium (LD) (Fig. **[1](#F1){ref-type="fig"}**). There is evidence for the involvement of the genes surrounding *IL1RL1* in human and experimental disease, and therefore the causal locus responsible for genetic association signals from this region is difficult to determine.

The *IL18R1*and *IL18RAP*genes code for the components of the heterodimeric IL18 receptor (the α and β chains, respectively). The cytokine IL18 is a modulator of innate and adaptive immune responses that acts by inducing T helper type 1 (Th1) cell differentiation and T and NK cell maturation or by activating IgE production and T helper type 2 (Th2) cell differentiation under specific cytokine milieus \[[@R10]-[@R12]\]. High levels of *IL18* mRNA and protein were observed in lungs of smokers and COPD patients \[[@R13]\] and expression of an alternatively-spliced variant of *IL18R1* was associated with atopy \[[@R14]\]. *IL18R1* expression was also higher in human primary keratinocytes derived from skin lesions of psoriasis and atopic dermatitis patients compared with healthy controls \[[@R15]\]. IL18 signaling has been implicated in host defense \[[@R16]\] and rheumatoid arthritis \[[@R17]\]. Additionally, genetic association data have implicated the IL18 receptor genes in asthmatic and allergic phenotypes \[[@R18],[@R19]\].

Expression of IL1RL1
--------------------

The gene transcription is initiated at two separate promoters: a proximal promoter and a distal promoter. The alternative usage of these two promoters leads to differential 3' processing of the mRNA isoforms \[[@R7],[@R8]\]. Three known isoforms are produced: isoform 1 which codes for IL1RL1 isoform A (aka ST2L), a long membrane-bound protein, isoform 2 which codes for IL1RL1 isoform B (aka sST2), a short soluble protein and a third isoform which codes for IL1RL1 isoform C (aka vST2) \[[@R9]\], a variant membrane-anchored form of the protein. The soluble form of IL1RL1 corresponds to the extra-cellular domain of IL1RL1 isoform A except for nine amino-acids in the C-terminal region.

IL1RL1 isoform A is mainly expressed on cells of hematopoietic provenance, mainly T cells \[[@R20]\]. It has been shown that binding of IL1RL1 isoform A with its ligand on the surface of basophils, eosinophils and mast cells promotes their activation \[[@R21]\], increased adhesion and survival \[[@R22]\] and degranulation \[[@R23]\], respectively. IL33/IL1RL1 isoform A has also been shown to play a role in activating macrophages \[[@R24],[@R25]\].

The short form, IL1RL1 isoform B, is expressed by various cells including epithelial cells, endothelial cells, fibroblasts and smooth muscle cells. This expression is augmented upon stimulation with IL1α, IL1β, TNFα, LPS and other factors inducing cell stress such as cardiac infarction and hypoxia \[[@R26]\]. The tissue distribution of IL1RL1 isoform B seems to be relatively ubiquitous, with the highest levels of the secreted form found in the lung followed by the heart and the brain \[[@R27]\].

Several studies show that the membrane-bound IL1RL1 protein acts as a specific marker for Th2 cells \[[@R20]\]. *In vitro* blockade of IL1RL1 signaling with recombinant IL1RL1 protein to compete with the endogenous receptor resulted in the abrogation of differentiation to and activation of Th2, but not Th1, effector cells \[[@R28]\]. Interestingly, IL1RL1 has been found to play a considerable role in a newly discovered immune type2 effector leukocytes, known as nuocytes \[[@R29]\]. An IL13-GFP mouse model was utilized to define these as cells not corresponding to a previously known leukocyte lineage that express ICOS, IL1RL1 and IL25R \[[@R29]\]. The nuocytes' function included the innate immune response to helminth infection with *Nippostrongylus brasiliensis*by secretion of high levels of IL13 in response to IL25 and IL33.

The ligand for IL1RL1 is a recently discovered member of the interleukin 1 family: IL33 \[[@R3]\]. The signaling of IL1RL1 isoform A binding to IL33 results in the activation of the Mitogen-Activated Protein kinases ERK1, ERK2 and p38 and the subsequent activation of NFκB \[[@R3],[@R23]\]. IL1RL1 isoform B corresponds to the extra-cellular domain of isoform A and *in vitro* studies have shown that it can also bind IL33 and act as a decoy receptor inhibiting the activation of NFκB \[[@R30]\] and the subsequent inflammatory response. This was confirmed in an animal model where introduction of soluble IL1RL1 decreased pro-inflammatory cytokine (IL4, IL5 and IL13) production in a murine asthma model after treatment with IL33. It was shown that this protective effect of the soluble IL1RL1 seems to be IL10 dependent in an animal model of ischemia reperfusion injury \[[@R31]\].

IL1RL1 IN DISEASE
=================

Asthma and other Respiratory Diseases
-------------------------------------

Increased eosinophil count is a phenotype associated with the majority of asthma cases and correlates with severity of the disease as well as response to glucocorticoid treatment \[[@R32]\]. Using asthma mouse models, it was shown that eosinophilic inflammation is significantly decreased following allergic stimuli in animals subjected to treatments with recombinant IL1RL1 or antibodies directed against the membrane-anchored protein \[[@R33],[@R34]\]. Soluble IL1RL1 has been shown to be sufficient to reduce experimental allergic airway inflammation using an intravenous IL1RL1 gene transfer mouse model \[[@R34]\], perhaps by acting as a decoy receptor. In addition, a ST2^-/-^knockdown mouse model of asthma showed decreased airway inflammation \[[@R35]\].

IL1RL1 expression has been shown to increase in murine \[[@R35]\] and human \[[@R36]\] asthmatic lungs; soluble IL1RL1 has been shown to increase in the serum of asthmatic patients during acute attacks, and this increase correlated with lung function decrease as well as an increase in the serum levels of the inflammatory cytokine IL5 \[[@R37]\]. Other *in vivo* studies of airway allergic inflammation demonstrated a clear involvement of soluble IL1RL1 protein in regulating a Th2 response after allergen challenge \[[@R35]\] as well as in the resolution of allergen-induced inflammation as assessed by airway hyper-responsiveness \[[@R38]\].

Since the late 1990s, genetic studies have shown linkage of chromosome 2 with asthma, lung function (as assessed by FEV~1~%VC, a common clinically-useful index for airflow limitation), eosinophilia and IgE levels \[[@R39]-[@R41]\].

Polymorphisms in *IL18R1*, a gene in tight LD with *IL1RL1*, were associated with asthma, atopic asthma and airway hyper-responsiveness using a candidate gene approach in a Danish population and the association consistently replicated in two other European populations \[[@R18]\]. In the same year, another candidate gene association study documented significant genetic association of the gene cluster containing *IL1RL1, IL18R1* and *IL18RAP* with asthma and atopy in a Dutch population \[[@R19]\]. Additional association evidence was reported by the same group using pathway analysis to detect gene-gene interactions in the Toll Like Receptor (TLR)-related pathway. IL1RL1 isoform B has been shown to down-regulate gene expression of TLR4 and TLR1 *in vitro* after treatment with LPS and *in vivo* in a LPS-induced shock mouse model \[[@R42]\].

Twenty-nine genes implicated in TLR regulation were selected for a pathway analysis in Dutch populations \[[@R43]\]. *IL1RL1* SNPs were associated with allergy and asthma phenotypes as single SNPs although the significance did not survive multiple testing correction. In addition, when gene x gene interactions were tested using the multifactor dimensionality reduction approach, *IL1RL1* SNPs were identified as interacting factors in analyses of IgE phenotypes \[[@R43]\].

In a study performed by our group in collaboration with others, we investigated three Canadian and one Australian populations but failed to detect any significant association with *IL1RL1* that survived correction for multiple comparisons \[[@R44]\]. The same cohorts, in addition to one American population, were used in an association study of genes in the vitamin D pathway with asthma and atopy phenotypes. *IL1RL1*SNPs were selected for this study based on the fact that *IL1RL1* was shown to be transcriptionally regulated by vitamin D \[[@R45]\]. The genotyping covered more variants of *IL1RL1* than the initial study and the number of candidate genes was substantially less (11 versus 120 genes). Significant associations of these variants were observed with asthma and atopy phenotypes \[[@R46]\].

Given the role of eosinophils in the pathogenesis of asthma, alleles that associate with increased eosinophil count could be detrimental in terms of asthma risk and severity. In a Genome Wide Association Study (GWAS) of eosinophil count in an Icelandic population, a SNP in *IL1RL1* (rs1420101) showed the most significant association. The A allele of rs1420101 associated with increased eosinophil count and in further analyses with increased serum IgE as well as with three asthma phenotypes (asthma, atopic asthma, non atopic asthma) in nine European populations and one east Asian population \[[@R47]\]. rs1420101 is an intronic SNP which is in high LD (r^2^greater than 80%) with a large number of other variants in *IL1RL1*, *IL18R1* and *IL18RAP*; this group of SNPs contains mostly intronic SNPs in addition to a coding-synonymous and a few 3' and 5' UTR SNPs. No functional studies have been performed thus far to determine the association-causing SNP.

It is of note that an association of a SNP in *IL33* (rs3939286) with eosinophil count, asthma and atopic asthma was reported in same study, although the *IL33* association with eosinophil count did not reach genome-wide significance. The same *IL33* SNP was associated with nasal polyposis in a Belgian population in a candidate gene study \[[@R48]\].

Wu *et al*. used GWAS data of childhood asthma in a Mexican population \[[@R49]\] to perform a candidate gene analysis. In this study, 237 genes were selected from human and animal model published studies of asthma to have at least one SNP associated with an asthma phenotype. They reported *IL1RL1* among the most significant associations. Furthermore, their results were subjected to multi-marker analysis, which confirmed *IL1RL1* as a significant finding as well as *IL18R1*.

Collectively, there is strong evidence for genetic association of *IL1RL1* with asthma and related phenotypes. This association is certainly very well supported by the biology of IL1RL1 and related proteins. IL33 is secreted by the airway epithelium in response to stress such as allergens or viruses, and binds to IL1RL1 isoform A on the surface of immune cells. There are excellent reviews about the central role of the epithelium in initiating and sustaining immune responses \[[@R50]\]; IL33/ IL1RL1 isoform A plays a crucial role in that process.

The binding of IL1RL1 isoform A and its ligand IL33 triggers the NFκB signaling pathway, which leads to the transcription of cytokines needed for a Th2 immune response. However, the role of IL1RL1 isoform B remains unclear. Several animal models and *in vitro* studies show that IL1RL1 isoform B prevents the IL33/ IL1RL1 isoform A signaling and consequently attenuates inflammation, indicating its role as a negative regulator of the pro-inflammatory IL33/ IL1RL1 isoform A axis. Human data on the other hand clearly demonstrate a consistent increase of IL1RL1 isoform B in an array of pathological conditions as well as the correlation of this increase with severity. Additionally, there was a report of an animal study showing that mice deficient in IL1RL1 showed attenuated airway inflammation after challenge with an allergen \[[@R51]\], suggesting that IL1RL1 isoform B might be participating in the excessive inflammation observed in asthma. However, the model used for this study was the transgenic TCR-mouse model; these animals are pre-disposed to autoimmune disorders because they carry rearranged TCR α and β genes from a diabetogenic T cell clone.

The above studies do not seem to be consistent with the antagonist role of IL1RL1 isoform B but rather indicate a possible involvement in the pathology. An alternative explanation would be that the increase of IL1RL1 isoform B is a means of preventing an exaggerated immune response but either occurs too late or is insufficient to remedy to the pathological state.

Evidently, soluble IL1RL1 plays a role in the regulation of the immune response, notably in severe disease. Exactly what that role is and the mechanisms underlying it need to be clarified in order to develop efficient strategies for developing therapeutics using the IL1RL1 proteins.

Recent human data in Chronic Obstructive Pulmonary Disease (COPD) seem to indicate an involvement of soluble IL1RL1 in the early stages of COPD \[[@R52]\]. This study however involved a small number of patients and needs replication.

Allergy and Immune Disorders
----------------------------

A SNP in the distal promoter region of *IL1RL1*, rs6543116 (-26999G/A), was associated with increased risk for atopic dermatitis and up-regulation of gene expression \[[@R53]\]. This study suggested a functional effect of rs6543116 as the A allele correlated with an up-regulation of the gene transcription as well as serum levels. The same group reported the association of serum levels of IL33 and SNPs in the *IL33* gene with Japanese cedar pollinosis, the most common form of allergic rhinitis in Japan \[[@R54]\]. In addition, Castano *et al*. found a protective association of *IL1RL1* SNPs with chronic rhinosinusitis using a cohort of surgery-unresponsive chronic rhinitis patients, this association was stronger in more severe disease \[[@R55]\].

IL33 signaling through IL1RL1 was shown to be involved in anaphylactic shock in an animal model study examining the response of IgE-sensitized mice to IL33 treatment \[[@R23]\]. The same authors had shown elevated IL33 levels in the serum of atopic patients undergoing surgery; this effect was demonstrated to derive purely from innate immunity as T or B cells were not required. The pathological effect could be prevented by treatment with anti-IL33 antibody or soluble IL1RL1 and was not observed in ST2^-/-^ animals \[[@R23]\].

*IL1RL1* and closely linked genes have been implicated in an array of autoimmune diseases. Levels of IL1RL1 isoform B have been shown to be increased in various conditions such as Systemic Lupus Erythematosus (SLE), sclerosis, and rheumatoid arthritis (RA) \[[@R56]\]. Mok *et al*. found that elevated serum IL1RL1 isoform B levels in SLE patients correlated with disease activity \[[@R57]\]. To date, GWAS performed in Chinese and European populations have not found association of *IL1RL1* SNPs with RA \[[@R58],[@R59]\].

Studies in animal models demonstrated that recombinant IL1RL1 isoform B protein, or anti-IL1RL1 antibody could significantly attenuate the severity of experimental arthritis \[[@R60],[@R61]\] and IL1RL1 knock-out mice were shown to develop less severe form of disease and had reduced pro-inflammatory cytokine production. Additionally, human studies have shown increased levels of IL33 and IL1RL1 in RA synovium paralleling increased inflammation \[[@R62]\]. Studies in animal models strongly suggest that the involvement of IL33/IL1RL1 in RA is through triggering mast cell degranulation in the RA synovium \[[@R63]\]. Although there is good evidence for a role of IL33/IL1RL1 in human and experimental arthritis, no SNPs in these genes were found associated with susceptibility to RA in GWAS data \[[@R64]\].

The IL1RL1/IL33 signaling axis was implicated in inflammatory bowel disease (IBD) for the first time in two recent studies characterizing IL1RL1 and IL33 protein and mRNA expression in IBD patients \[[@R65]\]. There was an increase in soluble IL1RL1 levels in the gut, which was mainly associated with the active state of ulcerative colitis, indicating a possible negative regulation of the IL1RL1/IL33 pathway in order to dampen the inflammation. Pastorelli *et al*. confirmed the observation of elevated levels of IL1RL1 and IL33 in the serum and mucosa of IBD patients; they also showed that anti-TNF decreased IL1RL1 isoform A levels and increased the soluble isoform making more decoy receptor available in order to sequester IL33 and reduce the inflammation \[[@R66]\].

A SNP 1.5 kb downstream of *IL18RAP* (rs917997) was associated with susceptibility to IBD in a Dutch population; the same SNP was associated with celiac disease in three European populations \[[@R67]\]. rs917997 along with another SNP in the intergenic region between *IL1RL1*and*IL18R1*(rs13015714) were associated with celiac disease in a GWAS of a UK population \[[@R68]\]. The same SNP downstream of *IL18RAP*(rs917997) was associated with Crohn\'s disease in a GWAS \[[@R69]\].

These genetic and mechanistic data suggest that IL1RL1/IL33 plays a role in the gut mucosa similar to the airway epithelium i.e. IL1RL1 isoform A/IL33 eliciting a Th2 immune response and IL1RL1 isoform B serving as a negative regulator.

There is evidence that IL1RL1 directly acts on macrophages to suppress their ability to produce pro-inflammatory cytokines \[[@R42]\]. Macrophages are instrumental in diabetes pathogenesis. In an animal model of diabetes (multiple low-dose streptozotocin-induced diabetes), Mensah-Brown *et al*. \[[@R70]\] showed that specific disruption of the *IL1RL1* gene significantly enhanced inflammation in their mouse model as estimated by an increase in cellular infiltration in pancreatic islets and a reduction in cells immuno-positive for insulin. Recently, a genetic linkage study demonstrated linkage of chromosome 2 with type 2 diabetes with a LOD score of 4.5 \[[@R71]\]. Follow-up genetic studies are warranted to narrow down the linkage signal and investigate specific SNP associations. This may lead to the identification of novel pathways in diabetes.

In summary, the available data on the involvement of IL1RL1 and its ligand IL33 in immune and autoimmune disorders are reasonably consistent; a clearer understanding of the balance between IL1RL1 isoform A/IL33, IL1RL1 isoform B/IL33 and its regulation is needed in order to make that axis a more attractive target for therapeutic intervention.

Cardiovascular Disease
----------------------

*In vitro*and animal model studies have demonstrated that IL33/IL1RL1 isoform A signaling protects cardiomyocytes from apoptosis by suppressing Caspase 3 activity and promoting the expression of anti-apoptotic proteins *in vitro* and improves survival in experimental myocardial infarction (MI) animals \[[@R72]\]. Human studies have shown an increase of soluble IL1RL1 after myocardial stress or injury, and MI \[[@R26],[@R73]\]; the levels correlated with diastolic load \[[@R74]\], cardiac abnormalities on electrocardiogram (ECG) and poor prognosis in dyspneic and MI patients \[[@R75]-[@R77]\]. In a study following 150 patients admitted to hospital with acutely destabilized heart failure, multiple serum samples were collected between admission and discharge and soluble IL1RL1 levels were measured. The results showed that IL1RL1 isoform B levels were a powerful predictor of 90-day mortality. Indeed, IL1RL1 isoform B serum levels are considered a reliable biomarker for heart failure \[[@R78],[@R79]\] as delineated by a recent review by Moore *et al*. \[[@R80]\]. A more recent study demonstrated for the first time that IL1RL1 isoform B could be used to predict left ventricular and infarct recovery after acute MI \[[@R81]\].

The company Critical Diagnostics in collaboration with the Brigham and Women's Hospital in Boston has developed a diagnosis kit called Presage that uses soluble IL1RL1 levels for diagnosis and prognosis of cardiovascular disease. However, this kit is not yet approved by the FDA for clinical use. Many U.S. and international patents protect the use of IL1RL1 for the diagnosis and prognosis in cardiovascular disease.

The fact that increased level of IL1RL1 is correlated with poor prognosis in different instances of cardiovascular disease points to a role of soluble IL1RL1 as marker for the severity of the immune response. Increased IL1RL1 isoform B is indicative of an overwhelming immune response that is hard to control and thus leads to unfavorable outcome in cardiovascular disease patients, such as after an MI.

Infections
----------

IL1RL1 isoform B levels correlate with sepsis severity and outcome \[[@R82]\]. A possible mechanism was recently described by Alves-Filho *et al*. \[[@R83]\]. Using the cecal ligation and puncture model in Balb-c mice \[[@R83]\], a widely used model for experimental sepsis, this group demonstrated that IL33 treatment was protective from peritonitis and enhanced bacterial clearance. Their data also show that the protective effect of IL33 treatment was achieved *via*the inhibition of a TLR-signaling-induced protein, GRK2. GRK2 plays a prominent role in sepsis as it down-regulates CXCR2 (a receptor for IL8, a chemokine that attracts neutrophils to infection sites) thus leading to inefficient clearance of bacteria.

In agreement with the role of IL1RL1 proteins in the promotion of Th2 responses, mRNA levels of both receptor and soluble forms of the IL1RL1 transcript were shown to be up-regulated in an animal model of *Toxoplasma gondii* parasitic infection and this up-regulation correlated with protection from the infection \[[@R84]\]. In addition, ST2^-/-^ knockout mice demonstrated increased susceptibility and more severe disease compared to wild type mice as assessed by weight loss, increased parasite transcript levels and typical disease pathology \[[@R84]\]. In 2008, a small study of a Somali population reported an association of a SNP in the 3'UTR of *IL18R1* (rs3213733) with variability in Rubella vaccine-induced humoral immunity \[[@R85]\]. It is interesting that the same SNP was recently shown to be associated with asthma in two different studies, in Mexican and Japanese populations \[[@R47],[@R86]\]. As LD patterns differ between populations, this suggests a potential functional role of this SNP in regulating gene expression/function.

Additional evidence for a role of the IL33/IL1RL1 axis in host defense comes from an animal study showing the protective role of IL33 in intestinal infection with nematodes \[[@R87]\].

In summary, IL1RL1 confers protection from infection, which is consistent with its involvement in the Th2 immune response. The increase in IL1RL1 signaling skews T cells to Th2 and prevents a parasite-specific Th1 polarized response.

Liver and Kidney Disorders
--------------------------

In a candidate gene association study of the course of Hepatitis C in a Japanese population, 103 genes including *IL1RL1* and *IL18R1* were investigated \[[@R88]\]. SNPs in both these genes as well as other genes involved in immune responses were significantly associated with serum levels of alanine aminotransferase (ALT). ALT levels are routinely used as a diagnostic test of liver function and elevated levels are an indicator of infections and other disorders. Nevertheless, this group's data were not corrected for multiple testing and need to be replicated in other populations.

An over-expression of IL1RL1 and IL33 mRNA in fibrotic liver was reported using mouse and human tissue sections \[[@R89]\].

CONCLUDING REMARKS
==================

The *IL1RL1* gene and its resulting soluble and receptor proteins have emerged as key regulators of the inflammatory process implicated in a large variety of human pathologies (see summary Table **[1](#T1){ref-type="table"}**).

IL1RL1 is important for both innate and adaptive immunity as IL1RL1 isoform A binding with its ligand IL33 leads to polarization of T helper cells into Th2 and also activates and promotes the degranulation of mast cells. The resulting inflammation is down-regulated by the soluble form of IL1RL1; levels of the latter are recognized as biomarkers for the severity of various conditions. Except for the functional analysis of the *IL1RL1* SNP rs6543116 associated with asthma and atopic dermatitis \[[@R36],[@R53]\], there has been no functional analysis of the disease-associated variants in *IL1RL1*; functional characterization of genetically-associated variants is necessary to determine the causal pathways leading to expression and/or function changes in the proteins.

As shown by numerous animal model studies, targeting the IL1RL1/IL33 axis is potentially a very promising therapeutic avenue for lung, heart and other immune and inflammatory disorders. In order to move the field forward, it will be important to investigate genetic association of the *IL1RL1* region (including the surrounding genes) in different populations with different LD patterns; this will permit a better understanding of the biology behind this region's involvement in immune and inflammatory disorders and thus facilitate and focus future therapeutic targeting efforts.

![Linkage disequilibrium in IL1RL1 and surrounding genes on chromosome 2q12 (102280 kb to 102500 kb) in the CEU HapMap population.](CG-11-591_F1){#F1}

  Gene               SNP                                      Chr. Loc.   SNP Location               Disease/Phenotype                         pValue                      Study                                                 Population                                                                   N                                            Refs.
  ------------------ ---------------------------------------- ----------- -------------------------- ----------------------------------------- --------------------------- ----------------------------------------------------- ---------------------------------------------------------------------------- -------------------------------------------- -------------------------------------------------------------
  IL1RL1             rs949963                                 102769786   5\' near-gene              Childhood asthma                          0.033                       Candidate gene study_follow-up to GWAS                Mexican                                                                      492 cases + both parents                     Wu *et al.*- J Allergy Clin Immunol 2010
  IL1R1              rs3917289                                102781911   intronic                   Childhood asthma                          0.022                       Candidate gene study_follow-up to GWAS                Mexican                                                                      492 cases + both parents                     Wu *et al.*- J Allergy Clin Immunol 2010
  IL1RL1             rs11685424                               102926981   5\' near-gene              Childhood asthma                          0.04                        Candidate gene study_follow-up to GWAS                Mexican                                                                      492 cases + both parents                     Wu *et al.*- J Allergy Clin Immunol 2010
  IL1RL1             rs11685480                               102927086   5\' near-gene              Specific IgE egg 1-2 years                0.02                        Candidate gene study-gene-gene interaction analysis   Dutch                                                                        3062 children (birth cohort)                 Reijmerink *et al.*- Allergy 2010
  IL1RL1             rs6543116                                102927726   promoter                   Atopic dermatitis                         0.000007                    Candidate SNP study                                   Japanese                                                                     452 cases / 636 controls                     Shimizu *et al.*- Hum Mol Genet 2005
  IL1RL1             rs1420089                                102938389   intronic                   Asthma                                    0.033                       Candidate gene study                                  French-Canadian founder population                                           72 families                                  Bossé *et al.*- Respir Res 2009
  IL1RL1             rs13431828                               102954653   5\' UTR                    Chronic rhinosinusitis                    0.008                       Candidate gene study                                  French-Canadian                                                              206 cases / 196 controls                     Castano *et al.*- Am J Rhinol Allergy 2009
  IL1RL1             rs13431828                               102954653   5\' UTR                    Childhood asthma                          0.0002                      Candidate gene study_follow-up to GWAS                Mexican                                                                      492 cases + both parents                     Wu *et al.*- J Allergy Clin Immunol 2010
  IL1RL1             rs1041973                                102955468   Cod.non.syn (78Ala\>Glu)   Atopy                                     0.046                       Candidate gene study                                  Canadian birth cohort                                                        98 families                                  Bossé *et al.*- Respir Res 2009
  IL1RL1             rs1041973                                102955468   Cod.non.syn (78Ala\>Glu)   Course of hepatitis C                     0.004                       Candidate gene study                                  Japanese                                                                     238 cases                                    Saito *et al.*- Biochem Biophys Res Commun 2004
  IL1RL1             rs1041973                                102955468   Cod.non.syn (78Ala\>Glu)   Childhood asthma                          0.00035                     Candidate gene study_follow-up to GWAS                Mexican                                                                      492 cases + both parents                     Wu *et al.*- J Allergy Clin Immunol 2010
  IL1RL1             rs1420101                                102957716   intronic                   Eosinophil count                          5.3 x 10^-14^               GWAS                                                  Icelandic                                                                    9392 individuals                             Gudbjartsson *et al.*- Nat Genet 2009
  IL1RL1             rs1420101                                102957716   intronic                   Asthma                                    5.5 x 10^-12^               Candidate gene study_follow-up to GWAS                9 European + 1 East Asian populations                                        7996 cases / 44890 controls                  Gudbjartsson *et al.*- Nat Genet 2009
  IL1RL1             rs2160203                                102960824   3\' UTR                    Chronic rhinosinusitis                    0.03                        Candidate gene study                                  French-Canadian                                                              206 cases / 196 controls                     Castano *et al.*- Am J Rhinol Allergy 2009
  IL1RL1             rs1946131                                102961929   intronic                   Asthma / Atopy                            0.015 / 0.050               Candidate gene study                                  French-Canadian founder population                                           53 / 42 families                             Bossé *et al.*- Respir Res 2009
  IL1RL1             rs17027006                               102965332   intronic                   Total IgE                                 0.02                        Candidate gene study-gene-gene interaction analysis   Dutch                                                                        3062 children (birth cohort)                 Reijmerink *et al.*- Allergy 2010
  IL1RL1             rs1921622                                102966067   intronic                   Specific IgE egg 1-2 years                0.04                        Candidate gene study-gene-gene interaction analysis   Dutch                                                                        3062 children (birth cohort)                 Reijmerink *et al.*- Allergy 2010
  IL1RL1             rs1921622                                102966067   intronic                   BHR / asthma / Total IgE                  0.014 / 0.038 / 0.027       Candidate gene study                                  Dutch                                                                        212 / 193 / 276 families                     Reijmerink *et al.*- J Allergy Clin Immunol 2008
  IL1RL1             rs10208293                               102966310   intronic                   Chronic rhinosinusitis                    0.03                        Candidate gene study                                  French-Canadian                                                              206 cases / 196 controls                     Castano *et al.*- Am J Rhinol Allergy 2009
  IL1RL1             rs10208293                               102966310   intronic                   Specific IgE indoor allergens 6-8 years   0.03                        Candidate gene study-gene-gene interaction analysis   Dutch                                                                        3062 children (birth cohort)                 Reijmerink *et al.*- Allergy 2010
  IL1RL1             rs1861246                                102966783   intronic                   BHR / asthma / Total IgE                  0.021 / 0.05 / 0.02         Candidate gene study                                  Dutch                                                                        175 / 163 / 230 families                     Reijmerink *et al.*- J Allergy Clin Immunol 2008
  IL1RL1             rs1861245                                102966906   intronic                   Asthma                                    0.032                       Candidate gene study                                  French-Canadian founder population                                           101 families                                 Bossé *et al.*- Respir Res 2009
  IL1RL1             rs4988957                                102968075   cod.syn                    Chronic rhinosinusitis                    0.03                        Candidate gene study                                  French-Canadian                                                              206 cases / 196 controls                     Castano *et al.*- Am J Rhinol Allergy 2009
  IL1RL1             rs10204137                               102968212   Cod.non.syn                Chronic rhinosinusitis                    0.04                        Candidate gene study                                  French-Canadian                                                              206 cases / 196 controls                     Castano *et al.*- Am J Rhinol Allergy 2009
  IL1RL1             rs10204137                               102968212   Cod.non.syn                Childhood asthma                          0.013                       Candidate gene study_follow-up to GWAS                Mexican                                                                      492 cases + both parents                     Wu *et al.*- J Allergy Clin Immunol 2010
  IL1RL1             rs10192157                               102968356   Cod.non.syn                Childhood asthma                          0.013                       Candidate gene study_follow-up to GWAS                Mexican                                                                      492 cases + both parents                     Wu *et al.*- J Allergy Clin Immunol 2010
  IL1RL1             rs10206753                               102968362   Cod.non.syn                Childhood asthma                          0.013                       Candidate gene study_follow-up to GWAS                Mexican                                                                      492 cases + both parents                     Wu *et al.*- J Allergy Clin Immunol 2010
  IL1RL1 / IL18R1    rs13015714                               102971865   intergenic                 Coeliac disease                           NS                          Candidate gene study_follow-up to GWAS                European (Swedish, Norwegian)                                                325 families                                 Amundsen *et al.*- Genes Immun 2010
  IL1RL1 / IL18R1    rs12999364                               102974129   intergenic                 BHR / asthma                              0.016 / 0.021               Candidate gene study                                  Dutch                                                                        198 / 185 families                           Reijmerink *et al.*- J Allergy Clin Immunol 2008
  IL18R1             rs2287037 (C-69T)                        102979028   5\' near-gene              Coal workers\' pneumoconiosis             NS                          Candidate gene study                                  French                                                                       200 individuals                              Nadif *et al.*- Eur Respir J 2006
  IL18R1             rs2287037                                102979028   5\' near-gene              Asthma                                    0.024                       Candidate gene study                                  European (Danish, British, Norwegian)                                        736 families                                 Zhu *et al.*- Eur J Hum Genet 2008
  IL18R1             rs1420099                                102980543   intronic                   Asthma / Atopic asthma                    0.00069 / 0.00008           Candidate gene study                                  European (Danish, British, Norwegian)                                        736 families                                 Zhu *et al.*- Eur J Hum Genet 2008
  IL18R1             rs1420098                                102984279   intronic                   Asthma                                    0.037                       Candidate gene study                                  European (Danish, British, Norwegian)                                        736 families                                 Zhu *et al.*- Eur J Hum Genet 2008
  IL18R1             rs1362348                                102984624   intronic                   Asthma / Atopic asthma / BHR              0.0013 / 0.00024 / 0.048    Candidate gene study                                  European (Danish, British, Norwegian)                                        736 families                                 Zhu *et al.*- Eur J Hum Genet 2008
  IL18R1             rs1558627                                102984684   intronic                   BHR / Total IgE                           0.049/.028                  Candidate gene study                                  Dutch                                                                        180 / 238 families                           Reijmerink *et al.*- J Allergy Clin Immunol 2008
  IL18R1             rs2058622                                102985424   intronic                   Atopic asthma                             0.045                       Candidate gene study                                  European (Danish, British, Norwegian)                                        736 families                                 Zhu *et al.*- Eur J Hum Genet 2008
  IL18R1             rs3771170                                102985980   intronic                   Humoral immunity to Rubella               0.0003                      Candidate gene study                                  Somali                                                                       89 individuals                               Dhiman *et al.*- Tissue Antigens 2008
  IL18R1             rs3771166                                102986222   intronic                   Childhood asthma                          0.011                       Candidate gene study_follow-up to GWAS                Mexican                                                                      492 cases + both parents                     Wu *et al.*- J Allergy Clin Immunol 2010
  IL18R1             rs1974675                                102986375   intronic                   Asthma / Atopic asthma / BHR              0.00005 / 0.00001 / 0.036   Candidate gene study                                  European (Danish, British, Norwegian)                                        736 families                                 Zhu *et al.*- Eur J Hum Genet 2008
  IL18R1             rs1465321                                102986618   intronic                   Humoral immunity to Rubella               0.009                       Candidate gene study                                  Somali                                                                       89 individuals                               Dhiman *et al.*- Tissue Antigens 2008
  IL18R1             rs2270297                                102992675   intronic                   Humoral immunity to Rubella               0.0002                      Candidate gene study                                  Somali                                                                       89 individuals                               Dhiman *et al.*- Tissue Antigens 2008
  IL18R1             rs2270297                                102992675   intronic                   BHR                                       0.048                       Candidate gene study                                  Dutch                                                                        185 families                                 Reijmerink *et al.*- J Allergy Clin Immunol 2008
  IL18R1             rs3213733                                102997884   intronic                   Humoral immunity to Rubella               0.009                       Candidate gene study                                  Somali                                                                       89 individuals                               Dhiman *et al.*- Tissue Antigens 2008
  IL18R1             rs3213733                                102997884   intronic                   Asthma                                    0.0035                      Candidate gene study                                  Japanese                                                                     288 cases / 1032 controls                    Imada *et al.*- BMC Res Notes 2009
  IL18R1             rs3213733                                102997884   intronic                   Childhood asthma                          0.0054                      Candidate gene study_follow-up to GWAS                Mexican                                                                      492 cases + both parents                     Wu *et al.*- J Allergy Clin Immunol 2010
  IL18R1             rs1035130                                103001402   cod.syn                    BHR / asthma                              0.048 / 0.046               Candidate gene study                                  Dutch                                                                        174 / 159 families                           Reijmerink *et al.*- J Allergy Clin Immunol 2008
  IL18R1             rs3755274                                103002395   intronic                   Humoral immunity to Rubella               0.009                       Candidate gene study                                  Somali                                                                       89 individuals                               Dhiman *et al.*- Tissue Antigens 2008
  IL18R1             rs2241117                                103003043   intronic                   Humoral immunity to Rubella               0.001                       Candidate gene study                                  Somali                                                                       89 individuals                               Dhiman *et al.*- Tissue Antigens 2008
  IL18R1             rs3771161                                103003961   intronic                   Humoral immunity to Rubella               0.009                       Candidate gene study                                  Somali                                                                       89 individuals                               Dhiman *et al.*- Tissue Antigens 2008
  IL18R1             rs4851004                                103009537   intronic                   Childhood asthma                          0.0079                      Candidate gene study_follow-up to GWAS                Mexican                                                                      492 cases + both parents                     Wu *et al.*- J Allergy Clin Immunol 2010
  IL18R1             rs2287033                                103011237   intronic                   Childhood asthma                          0.0063                      Candidate gene study_follow-up to GWAS                Mexican                                                                      492 cases + both parents                     Wu *et al.*- J Allergy Clin Immunol 2010
  IL18R1             rs3732127                                103013750   3\' UTR                    Humoral immunity to Rubella               0.009                       Candidate gene study                                  Somali                                                                       89 individuals                               Dhiman *et al.*- Tissue Antigens 2008
  IL18R1             rs1420094                                103015687   3\' UTR                    Childhood asthma                          0.0063                      Candidate gene study_follow-up to GWAS                Mexican                                                                      492 cases + both parents                     Wu *et al.*- J Allergy Clin Immunol 2010
  IL18R1             rs1420094                                103015687   3\' UTR                    Atopic asthma                             0.0063                      Candidate gene study                                  European (Danish, British, Norwegian)                                        736 families                                 Zhu *et al.*- Eur J Hum Genet 2008
  IL18R1 / IL18RAP   rs1035127                                103019919   intergenic                 Crohn\'s disease                          1.2 x 10^-4^                GWAS                                                  Caucasian (American, Canadian, Belgian, French, British)                     2325 cases / 1809 controls + 1339 families   Barrett *et al.*- Nat Genet 2008
  IL18RAP            rs1420106                                103035044   5\' near-gene              BHR / Total IgE                           0.023 / 0.012               Candidate gene study                                  Dutch                                                                        184 / 234 families                           Reijmerink *et al.*- J Allergy Clin Immunol 2008
  IL18RAP            rs1420100                                103037002   intronic                   Lumbar disc signal intensity              0.005                       Candidate gene study                                  Finnish                                                                      588 individuals                              Videman *et al.*- Arthritis Rheum 2009
  IL18RAP            rs2272127                                103039873   intronic                   Schizophrenia+Herpes seropositivity       0.03                        Candidate gene study                                  Caucasian (Amercican)                                                        478 cases / 501 controls                     Shirts *et al.*- Am J Med Genet B Neuropsychiatr Genet 2008
  IL18RAP            rs917997                                 103070568   intergenic                 Coeliac disease                           8.49 x 10^-10^              Candidate gene study_follow-up to GWAS                Northern European                                                            767 cases / 1422 controls                    Hunt *et al.*- Nat Genet 2008
  IL18RAP            rs917997                                 103070568   intergenic                 Type 1 diabetes                           8.03 x 10^-5^               Candidate gene study                                  Caucasian (Irish, British, American, Romanian, Danish, Norwegian, Finnish)   8064 cases / 9339 controls                   Smyth *et al.*- N Engl J Med 2008
  IL18RAP            rs917997                                 103070568   intergenic                 Crohn\'s disease                          2.2 x 10^-6^                Candidate gene study                                  European                                                                     1689 cases / 6197 controls                   Wang *et al.*- Hum Mol genet 2010
  IL18RAP            rs917997                                 103070568   intergenic                 IBD                                       1.9 x 10^-8^                Candidate gene study                                  Dutch                                                                        1851 cases / 1936 controls                   Zhernakova *et al.*- Am J Hum Genet 2008
  Chr 2              \-                                       \-          \-                         Type 2 diabetes                           LOD=4.53                    Genetic linkage study                                 African-American                                                             580 families                                 Elbein *et al.*- Diabetes 2009
  IL18RAP            6 Tag SNPs                               \-          \-                         Cardiovascular disease                    NS                          Candidate gene study                                  European                                                                     1416 cases / 1772 Controls                   Grisoni *et al.*- BMC Med Genet 2009
  IL18R1             5 Tag SNPs                               \-          \-                         Cardiovascular disease                    NS                          Candidate gene study                                  European                                                                     1416 cases / 1772 Controls                   Grisoni *et al.*- BMC Med Genet 2009
  IL1RL1 / IL18R1    Haplo: rs10206753/rs12999364/rs1420099   \-          \-                         BHR                                       0.006                       Candidate gene study                                  Dutch                                                                        179 families                                 Reijmerink *et al.*- J Allergy Clin Immunol 2008
  IL18R1             Haplo:rs1420099/rs1558627/rs2270297      \-          \-                         Asthma                                    0.002                       Candidate gene study                                  Dutch                                                                        180 families                                 Reijmerink *et al.*- J Allergy Clin Immunol 2008
  IL1RL1             Haplo:rs1921622/rs1861246/rs10206753     \-          \-                         BHR / asthma / Total IgE                  0.0009 / 0.0008 / 0.007     Candidate gene study                                  Dutch                                                                        192 / 170 / 245 families                     Reijmerink *et al.*- J Allergy Clin Immunol 2008
  IL18R1 / IL18RAP   22 candidate SNPs                        \-          \-                         Cardiovascular mortality                  NS                          Candidate gene study                                  German                                                                       142 cases / 1142 controls                    Tiret *et al.*- Circulation 2005
  IL1RL1             multimarker (11)                         \-          \-                         Childhood asthma                          2.2 x 10^-4^                Candidate gene study_follow-up to GWAS                Mexican                                                                      492 cases + both parents                     Wu *et al.*- J Allergy Clin Immunol 2010
  IL18R1             multimarker (9)                          \-          \-                         Childhood asthma                          9 x 10^-3^                  Candidate gene study_follow-up to GWAS                Mexican                                                                      492 cases + both parents                     Wu *et al.*- J Allergy Clin Immunol 2010

**Abbreviations** IBDInflammatory bowel diseaseBHRBronchial hyper-responsivenessGWASGenome-wide association studyChr.LocChromosal location based on NCBI build 37.1Chr 2Chromosome 2HaploHaplotypeNSNon significantCod.non.synCoding non synonymous SNPCod.synCoding synonymous SNP

Same SNPs are highlited with the same color; different colors are merely for ease of viewing, and are inconsequential.
